WS
AMPE

Wedbush Securities’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Wedbush Securities’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-220
Closed -$63K – 1022
2020
Q3 		$63K Sell
220
-87
-28% -$21.6K 0.01% 863
2020
Q2 		$59K Sell
307
-129
-30% -$21.5K 0.01% 896
2020
Q1 		$54K Buy
436
+93
+27% +$16.8K 0.01% 821
2019
Q4 		$60K Hold
343
– – 0.01% 958
2019
Q3 		$52K Sell
343
-153
-31% -$20.4K 0.01% 937
2019
Q2 		$58K Sell
496
-593
-54% -$93.9K 0.01% 941
2019
Q1 		$184K Buy
+1,089
New +$187K 0.02% 793

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Wedbush Securities's AMPE Position: Q4 2020 in Review

Wedbush Securities sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2020, closing a stake of 220 shares — an estimated $63K sold.

Wedbush Securities first reported a position in AMPE in Q1 2019 and held it in 7 quarters. The position peaked at $184K in Q1 2019. 103 funds tracked by Wall St. Rank hold AMPE as of Q4 2020.

  • Wedbush Securities reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2020 after selling out during the quarter.
  • Wedbush Securities sold 220 Ampio Pharmaceuticals Inc. shares in Q4 2020, an estimated $63K.
  • Wedbush Securities first reported a position in Ampio Pharmaceuticals Inc. in Q1 2019 and held it in 7 quarters.
  • Wedbush Securities's Ampio Pharmaceuticals Inc. position peaked at $184K in Q1 2019.
  • 103 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2020.

Based on Wedbush Securities's 13F filing for Q4 2020, filed 16 Feb 2021.